1. Home
  2. LUCY vs UBX Comparison

LUCY vs UBX Comparison

Compare LUCY & UBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LUCY
  • UBX
  • Stock Information
  • Founded
  • LUCY 2017
  • UBX 2009
  • Country
  • LUCY United States
  • UBX United States
  • Employees
  • LUCY N/A
  • UBX N/A
  • Industry
  • LUCY Ophthalmic Goods
  • UBX Biotechnology: Pharmaceutical Preparations
  • Sector
  • LUCY Health Care
  • UBX Health Care
  • Exchange
  • LUCY Nasdaq
  • UBX Nasdaq
  • Market Cap
  • LUCY 14.5M
  • UBX 16.5M
  • IPO Year
  • LUCY 2022
  • UBX 2018
  • Fundamental
  • Price
  • LUCY $5.89
  • UBX $1.73
  • Analyst Decision
  • LUCY Strong Buy
  • UBX Strong Buy
  • Analyst Count
  • LUCY 1
  • UBX 2
  • Target Price
  • LUCY $20.00
  • UBX $7.00
  • AVG Volume (30 Days)
  • LUCY 48.3K
  • UBX 303.9K
  • Earning Date
  • LUCY 11-12-2024
  • UBX 11-04-2024
  • Dividend Yield
  • LUCY N/A
  • UBX N/A
  • EPS Growth
  • LUCY N/A
  • UBX N/A
  • EPS
  • LUCY N/A
  • UBX N/A
  • Revenue
  • LUCY $1,561,506.00
  • UBX N/A
  • Revenue This Year
  • LUCY $68.16
  • UBX N/A
  • Revenue Next Year
  • LUCY $636.84
  • UBX $33.62
  • P/E Ratio
  • LUCY N/A
  • UBX N/A
  • Revenue Growth
  • LUCY 158.62
  • UBX N/A
  • 52 Week Low
  • LUCY $3.26
  • UBX $0.94
  • 52 Week High
  • LUCY $27.20
  • UBX $2.02
  • Technical
  • Relative Strength Index (RSI)
  • LUCY 49.99
  • UBX 63.32
  • Support Level
  • LUCY $5.45
  • UBX $1.56
  • Resistance Level
  • LUCY $6.04
  • UBX $1.85
  • Average True Range (ATR)
  • LUCY 0.51
  • UBX 0.22
  • MACD
  • LUCY 0.08
  • UBX 0.05
  • Stochastic Oscillator
  • LUCY 51.53
  • UBX 75.96

About LUCY Innovative Eyewear Inc.

Innovative Eyewear Inc is engaged in developing and selling eyeglasses and sunglasses, which are designed to allow customers to remain connected to their digital lives, while also offering prescription eyewear and sun protection. Its products Lucyd Lyte glasses enable the wearer to listen to music, take and make calls, and use voice assistants to perform many common smartphone tasks hands free.

About UBX Unity Biotechnology Inc.

Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities unique to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases. Its drug candidates include, UBX1325 is being developed for age-related diseases of the eye, including diabetic macular edema, or DME, UBX2089, which is a circulating hormone primarily produced in the kidneys and choroid plexus of the brain, which is being researched for multiple neurology indications, and UBX2050.

Share on Social Networks: